跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
cell therapy (aging)
首页
药物
cell therapy (aging)
cell therapy (aging)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pro-neurogenic compounds
US 9962368 B2
申请人: MCKNIGHT STEVEN L
优先权: 2012
US
6 件公开
US 9095572 B2
申请人: MCKNIGHT STEVEN L
优先权: 2011
US
4 件公开
US 9701676 B2
申请人: UNIV TEXAS
优先权: 2013
US
2 件公开
CN 108329253 A
申请人: UNIV TEXAS
优先权: 2012
CN
Anti-depression compounds
US 9162980 B2
申请人: UNIV TEXAS
优先权: 2014
US
4 件公开
SENOLYTIC CAR-T CELLS TARGETING UPAR, A CELL SURFACE AND SECRETED SENESCENCE BIOMARKER
EP 3917966 A4
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2019
EP
US
WO
3 件公开
METHOD TO GENERATE IMPROVING CAR-T CELLS
EP 4598565 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
EP
US
WO
3 件公开
Selective androgen receptor modulators and methods of use thereof
EP 1764357 A1
申请人: UNIV TENNESSEE RES FOUNDATION
优先权: 2002
CN
EP
3 件公开
Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
US 7776320 B2
申请人: UNIV CALIFORNIA
优先权: 2001
US
3 件公开
Heterocyclic selective androgen receptor modulators and methods of use thereof
US 7214693 B2
申请人: UNIV TENNESSEE RES FOUNDATION
优先权: 2003
US
3 件公开
Methylene-bridged selective androgen receptor modulators and methods of use thereof
US 7253210 B2
申请人: UNIV TENNESSEE RES FOUNDATION
优先权: 2003
US
3 件公开
Methods of use for IL-22 promoting rejuvenation of thymic and bone marrow function
US 9119824 B2
申请人: DUDAKOV JARROD
优先权: 2012
US
3 件公开
Metabolites of selective androgen receptor modulators and methods of use thereof
CN 1972682 A
申请人: UNIV TENNESSEE RES FOUNDATION
优先权: 2004
CN
US
2 件公开
第 1 / 7 页
上一页
下一页
药物
反馈